CareDx (CDNA) EBIT (2013 - 2026)

CareDx has disclosed EBIT across 14 years of filings, most recently posting $1.2 million for Q1 2026.

• EBIT for Q1 2026 came in at $1.2 million, up 108.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.2 million (down 132.45% YoY), and the FY2025 annual result was -$30.8 million, down 175.51% from the prior year.
• EBIT came in at $1.2 million for Q1 2026 at CareDx, up from -$6.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $84.4 million in Q4 2024 to a low of -$122.6 million in Q4 2023.
• The 5-year median for EBIT is -$17.3 million (2022), against an average of -$15.8 million.
• Across the five-year window, EBIT plunged 2120.63% in 2022 and jumped 168.81% in 2024, its largest moves.
• CareDx's EBIT stood at -$19.1 million in 2022, then slumped by 541.38% to -$122.6 million in 2023, then jumped by 168.81% to $84.4 million in 2024, then tumbled by 107.16% to -$6.0 million in 2025, then jumped by 119.83% to $1.2 million in 2026.
• The last three EBIT figures came in at $1.2 million (Q1 2026), -$6.0 million (Q4 2025), and -$246000.0 (Q3 2025), per Business Quant data.